Sweden’s Public Wellbeing Company stated on Monday it really helpful to use Pfizer-BioNTech’s, Comirnaty vaccine in opposition to COVID-19 for youngsters between 12-15, opting in opposition to rival Moderna’s Spikevax.
The European Medicines Company authorized using Comirnaty in Might, whereas Spikevax was given the nod for youngsters over 12 in July.
“All in all, we see a determination to choose on the vaccine that we all know fundamentally the most about and that’s most well-proven on the subject of vaccinating youngsters between 12 and 15 years of age,” Anders Tegnell, head of the division and state epidemiologist on the Wellbeing Company stated.
The company stated there was extra information about Comirnaty’s use on youngsters.
“That is why Spikevax shouldn’t be really helpful for the youngest age group in Sweden,” the Company stated in a press release.
In September, the Company stated that youngsters aged 12 and over can be provided a COVID vaccination beginning October 11.